3×3 Study on bioequivalence of mycophenolate mofetil preparations in healthy male volunteers
Chinese Journal of Clinical Pharmacy(2007)
Abstract
AIM To study the bioequivalence of mycophenolate mofetil tablets,capsules and imported preparation(CellCept) by Latin square design. METHODS The serum concentration of 24 volunteers were determined by HPLC after a single oral does of 500 mg of mycophenolate mofetil tablets,capsules and imported preparation in a randomized crossover design.The pharmacokinetic parameters were calculated and the relative bioavailability and bioequivalence of three formulations were evaluated.RESULTS The pharmacokinetic parameters of mycophenolate mofetil tablets,capsules and imported preparation were as follows: AUC0→48:(39.74±8.61),(38.06±9.01)and(36.21±9.17)mg·h·L-1;AUC0→∞:(44.02±10.62),(40.91±9.54)and(39.82±9.21)mg·h·L-1.ρmax:(20.19±9.63),(17.42±6.03)and(18.48±7.06)mg·L-1.tmax;(0.74±0.64),(0.72±0.35)and(0.56±0.20)h;t12:(13.43±4.58),(12.20±3.09) and(13.59±5.40)h;MRT:(14.95±5.85),(13.42±2.83)and(14.40±5.47)h,respectively.CONCLUSION The results indicate that the three mycophenolate mofetil formμlations are bioequivalent.
MoreTranslated text
Key words
HPLC,mycophenolate mofetil,bioequivalence,mycophenolic acid
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined